Category: BA.1
Multiple hypermutated SARS-CoV-2 sequences that may have been created by molnupiravir
Molnupiravir, a drug used to treat SARS-CoV-2 infections, has received a lot of press attention since its launch, and not all of it has been positive.… ...More...
Long Covid: Lingering cough more common in Omicron patients
Patients suffering from COVID-19 after-effects were more likely to have persistent coughs and fatigue if they were infected with the Omicron variant instead of the Delta or other strains, a survey showed.… ...More...
Spillover of new BA.1 sublineage from persistently infected COVID patient into the community
“The new BA.1 sub-lineage transmitted to five independent cases, including two reported in GISAID from a different surveillance effort”…
Gisaid: BA.1 sublineage with T6001C and S mutations: S:E96D, S:L167T, S:R346T, S:L455W, S:K458M, S:E484V, S:H681R, S:P688V, detected in New York, USA #663.… ...More...
Vietnam: Severe liver and brain damage in child after Covid-19 infection
A 13-year-old boy just recovered from Covid-19 suddenly returned to fever, red skin, red eyes, the doctor diagnosed multi-system inflammatory syndrome, brain damage.… ...More...
Japan: New BA.1/BA.2 recombinant discovered
Japanese researchers have detected a new type of the Omicron variant which is a recombination of the BA.1 and more contagious BA.2 strains of the Omicron.… ...More...
China: 16 cases of Omicron BA.2.3 reported in Yantai, Shandong
16 cases of Omicron BA.2.3, were reported on Monday in Yantai, East China’s Shandong Province, the first time the strain has been detected in the Chinese mainland.… ...More...
France: XD recombinant lacks a competitive advantage over BA.2
France has just published a new risk analysis for SARS-CoV-2 variants circulating in the country.… ...More...
China: 50 SARS-CoV-2 sequences uploaded to Gisaid
Gisaid have published a report recently on fifty SARS-CoV-2 genome sequences uploaded by China which seems to have gone largely unnoticed by the mainstream media.… ...More...
UK ONS: 2.7% of the British population reporting Long Covid symptoms
An estimated 1.7 million people living in private households in the UK (2.7% of the population) were experiencing self-reported long COVID as of 5 March 2022
The estimates presented in this analysis relate to self-reported long COVID, as experienced by study participants who responded to a representative survey, rather than clinically diagnosed ongoing symptomatic COVID-19 or post-COVID-19 syndrome in the full population.… ...More...
SARS-CoV-2: New recombinants designated XG, XH, XJ, XK and XL
SARS_CoV-2 recombinants are being designated almost on a daily basis now.… ...More...